From those 74 genes, we selected two final candidates overexpressed in NASH but not in fatty liver: AKR1B10 (Aldo-Keto Reductase Family 1 Member B10) and FABP5 (Fatty Acid Binding Protein 5). This evidence concerns the gene AKR1B10 and metabolic dysfunction-associated steatohepatitis.